tiprankstipranks
The Fly

HCA Healthcare’s Q2 results highlight strong utilization, says Goldman Sachs

HCA Healthcare’s Q2 results highlight strong utilization, says Goldman Sachs

Goldman Sachs keeps a Neutral rating and $340 price target on HCA Healthcare after its Q2 earnigns beat and guidance raise. The company’s Q2 performance highlights a continued strong utilization environment, strong payor mix and acuity, and effective cost containment, the analyst tells investors in a research note.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com